D
Voyageur Pharmaceuticals Ltd. VM.V
TSX
Recommendation
Prev Close
Volume
--
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)

02/28/2025 11/30/2024 08/31/2024 05/31/2024 02/29/2024
Revenue -- -- -- -- --
Total Other Revenue -- -- -- -- --
Total Revenue -- -- -- -- --
Cost of Revenue -- -- -- -- --
Gross Profit -- -- -- -- --
SG&A Expenses 468.20K 290.60K 229.10K 373.80K 217.10K
Depreciation & Amortization 200.00 300.00 300.00 300.00 300.00
Other Operating Expenses -- -- -- -- --
Total Operating Expenses 468.40K 290.90K 229.40K 374.10K 217.40K
Operating Income -468.40K -290.90K -229.40K -374.10K -217.40K
Income Before Tax -571.30K -333.30K -262.20K -412.30K -244.80K
Income Tax Expenses -- -- -- -- --
Earnings from Continuing Operations -571.30K -333.30K -262.20K -412.30K -244.80K
Earnings from Discontinued Operations -- -- -- -- --
Extraordinary Item & Accounting Change -- -- -- -- --
Minority Interest in Earnings -- -- -- -- --
Net Income -571.30K -333.30K -262.20K -412.30K -244.80K
EBIT -468.40K -290.90K -229.40K -374.10K -217.40K
EBITDA -468.20K -290.60K -229.10K -373.80K -217.10K
EPS Basic 0.00 0.00 0.00 0.00 0.00
Normalized Basic EPS 0.00 0.00 0.00 0.00 0.00
EPS Diluted 0.00 0.00 0.00 0.00 0.00
Normalized Diluted EPS 0.00 0.00 0.00 0.00 0.00
Average Basic Shares Outstanding 155.52M 139.39M 139.45M 138.88M 132.74M
Average Diluted Shares Outstanding 155.52M 139.39M 139.45M 138.88M 132.74M
Dividend Per Share -- -- -- -- --
Payout Ratio -- -- -- -- --